Colorectal Cancer Research Today is a free monthly online journal that collates and summarizes the latest research about Colorectal Cancer, including details on symptoms, genetics, screening, treatment, information.

Volume 5 (2008), Issue 1 (January)

1. Sulindac and its metabolites induce carcinogen metabolizing enzymes in human colon cancer cells.
   Int J Cancer, 122(5): 990-8. [Abstract] [Full-text]
2. Uptake of two 10B-compounds in liver metastases of colorectal adenocarcinoma for extracorporeal irradiation with boron neutron capture therapy (EORTC Trial 11001).
   Int J Cancer, 122(5): 1164-71. [Abstract] [Full-text]
3. Hereditary nonpolyposis colorectal cancer in endometrial cancer patients.
   Int J Cancer, 122(5): 1077-81. [Abstract] [Full-text]
4. Herpes simplex virus type 1 preferentially targets human colon carcinoma: role of extracellular matrix.
   J Virol, 82(2): 999-1010. [Abstract] [Full-text]
5. The intestine-specific homeobox gene Cdx2 decreases mobility and antagonizes dissemination of colon cancer cells.
   Oncogene, 27(1): 107-15. [Abstract] [Full-text]
6. Targeting FGF19 inhibits tumor growth in colon cancer xenograft and FGF19 transgenic hepatocellular carcinoma models.
   Oncogene, 27(1): 85-97. [Abstract] [Full-text]
7. The incidence of lateral pelvic side-wall nodal involvement in low rectal cancer may be similar in Japan and the West.
   Br J Surg, 95(1): 33-49. [Abstract] [Full-text]
8. Mismatch repair protein expression in Amsterdam II criteria-positive patients in Taiwan.
   Br J Surg, 95(1): 102-10. [Abstract] [Full-text]
9. TLR4 signaling in cancer cells promotes chemoattraction of immature dendritic cells via autocrine CCL20.
   Biochem Biophys Res Commun, 366(3): 852-6. [Abstract] [Full-text]
10. Compressibility of gastrointestinal tract tumors during transabdominal sonographic examination: a clue to the diagnosis of gastrointestinal lymphoma.
    J Clin Ultrasound, 36(2): 59-62. [Abstract] [Full-text]
11. Metastasis from a primary angiosarcoma of the scalp to the colon: sonographic and CT findings.
    J Clin Ultrasound, 36(2): 110-2. [Abstract] [Full-text]
12. What is the role for the circumferential margin in the modern treatment of rectal cancer?
    J Clin Oncol, 26(2): 303-12. [Abstract] [Full-text]
13. Response-independent survival benefit in metastatic colorectal cancer: a comparative analysis of N9741 and AVF2107.
    J Clin Oncol, 26(2): 183-9. [Abstract] [Full-text]
14. A phase I and pharmacokinetic study of OSI-7904L, a liposomal thymidylate synthase inhibitor in combination with oxaliplatin in patients with advanced colorectal cancer.
    Cancer Chemother Pharmacol, 61(4): 579-85. [Abstract] [Full-text]
15. Expression level of thymidylate synthase mRNA reflects 5-fluorouracil sensitivity with low dose and long duration in primary colorectal cancer.
    Cancer Chemother Pharmacol, 61(4): 587-94. [Abstract] [Full-text]
16. Underuse of colorectal cancer screening in a cohort of Medicare beneficiaries.
    Cancer, 112(2): 293-9. [Abstract] [Full-text]
17. Racial differences in colorectal cancer screening practices and knowledge within a low-income population.
    Cancer, 112(2): 391-8. [Abstract] [Full-text]
18. Colorectal liver metastases contract centripetally with a response to chemotherapy: a histomorphologic study.
    Cancer, 112(2): 362-71. [Abstract] [Full-text]
19. Application of distance matrices to define associations between acute toxicities in colorectal cancer patients receiving chemotherapy.
    Cancer, 112(2): 284-92. [Abstract] [Full-text]
20. The bone morphogenetic protein pathway is active in human colon adenomas and inactivated in colorectal cancer.
    Cancer, 112(2): 300-6. [Abstract] [Full-text]
21. Signal pathway profiling of epithelial and stromal compartments of colonic carcinoma reveals epithelial-mesenchymal transition.
    Oncogene, 27(3): 323-31. [Abstract] [Full-text]
22. Polymorphisms in the methylenetetrahydrofolate reductase (MTHFR) gene, intakes of folate and related B vitamins and colorectal cancer: a case-control study in a population with relatively low folate intake.
    Br J Nutr, 99(2): 379-89. [Abstract] [Full-text]
23. Alcohol dehydrogenase (ADH) isoenzymes and aldehyde dehydrogenase (ALDH) activity in the sera of patients with colorectal cancer.
    Clin Exp Med, 7(4): 154-7. [Abstract] [Full-text]
24. Confocal chromoscopic endomicroscopy is superior to chromoscopy alone for the detection and characterisation of intraepithelial neoplasia in chronic ulcerative colitis.
    Gut, 57(2): 196-204. [Abstract] [Full-text]
25. The effects of population-based faecal occult blood test screening upon emergency colorectal cancer admissions in Coventry and north Warwickshire.
    Gut, 57(2): 218-22. [Abstract] [Full-text]
26. Prognostic factors and preoperative radiation therapy associated with sphincter preservation in patients with resectable rectal cancer.
    Am J Surg, 195(2): 239-43. [Abstract] [Full-text]
27. Results of laparoscopic anterior resection for rectal adenocarcinoma: retrospective analysis of 157 cases.
    Am J Surg, 195(2): 233-8. [Abstract] [Full-text]
28. Colorectal carcinoma in children and adolescents: the experience of the Istituto Nazionale Tumori of Milan, Italy.
    Pediatr Blood Cancer, 50(3): 588-93. [Abstract] [Full-text]
29. Therapeutic targeting of neuropilin-2 on colorectal carcinoma cells implanted in the murine liver.
    J Natl Cancer Inst, 100(2): 109-20. [Abstract] [Full-text]
30. The transcriptional repressor ZEB1 promotes metastasis and loss of cell polarity in cancer.
    Cancer Res, 68(2): 537-44. [Abstract] [Full-text]
31. Multiple rare nonsynonymous variants in the adenomatous polyposis coli gene predispose to colorectal adenomas.
    Cancer Res, 68(2): 358-63. [Abstract] [Full-text]
32. Self-expanding metallic stent insertion in the proximal colon.
    Colorectal Dis, 10(2): 194-6. [Abstract] [Full-text]
33. Epidermal growth factor receptor in colorectal carcinoma: correlation with clinico-pathological prognostic factors.
    Colorectal Dis, 10(2): 170-8. [Abstract] [Full-text]
34. Patient personality predicts postoperative stay after colorectal cancer resection.
    Colorectal Dis, 10(2): 151-6. [Abstract] [Full-text]
35. Transanal endoscopic microsurgery: local recurrence rate following resection of rectal cancer.
    Colorectal Dis, 10(2): 187-93. [Abstract] [Full-text]
36. A 6-year review of surgical morbidity and oncological outcome after high anterior resection for colorectal malignancy with and without splenic flexure mobilization.
    Colorectal Dis, 10(2): 165-9. [Abstract] [Full-text]
37. The impact of surgeon and pathologist on lymph node retrieval in colorectal cancer and its impact on survival for patients with Dukes' stage B disease.
    Colorectal Dis, 10(2): 157-64. [Abstract] [Full-text]
38. Can targeted intervention in CRC patients' relatives influence screening behaviour? A pilot study.
    Colorectal Dis, 10(2): 179-86. [Abstract] [Full-text]
39. Human immunodeficiency virus-associated squamous cell cancer of the anus: epidemiology and outcomes in the highly active antiretroviral therapy era.
    J Clin Oncol, 26(3): 474-9. [Abstract] [Full-text]
40. Individualized prediction of colon cancer recurrence using a nomogram.
    J Clin Oncol, 26(3): 380-5. [Abstract] [Full-text]
41. KRAS mutations as an independent prognostic factor in patients with advanced colorectal cancer treated with cetuximab.
    J Clin Oncol, 26(3): 374-9. [Abstract] [Full-text]
42. cT3N0 rectal cancer: potential overtreatment with preoperative chemoradiotherapy is warranted.
    J Clin Oncol, 26(3): 368-73. [Abstract] [Full-text]
43. Projected impact of colorectal cancer screening with computerized tomographic colonography on current radiological capacity in Europe.
    Aliment Pharmacol Ther, 27(4): 366-74. [Abstract] [Full-text]
44. Algorithms for the surgical management of retrorectal tumours.
    Br J Surg, 95(2): 214-21. [Abstract] [Full-text]
45. Prognostic significance of magnetic resonance imaging-detected extramural vascular invasion in rectal cancer.
    Br J Surg, 95(2): 229-36. [Abstract] [Full-text]
46. Late gastrointestinal disorders after rectal cancer surgery with and without preoperative radiation therapy.
    Br J Surg, 95(2): 206-13. [Abstract] [Full-text]
47. Patient factors influencing conversion from laparoscopically assisted to open surgery for colorectal cancer.
    Br J Surg, 95(2): 199-205. [Abstract] [Full-text]
48. Surgeon's awareness of the synchronous liver metastases during colorectal cancer resection may affect outcome.
    Eur J Surg Oncol, 34(2): 180-4. [Abstract] [Full-text]
49. The "Fas counterattack" is not an active mode of tumor immune evasion in colorectal cancer with high-level microsatellite instability.
    Hum Pathol, 39(2): 243-50. [Abstract] [Full-text]
50. Increased expression of thioredoxin-1, vascular endothelial growth factor, and redox factor-1 is associated with poor prognosis in patients with liver metastasis from colorectal cancer.
    Hum Pathol, 39(2): 201-8. [Abstract] [Full-text]
51. Randomized, multicenter, phase IIb study of preoperative chemoradiotherapy in T3 mid-distal rectal cancer: raltitrexed + oxaliplatin + radiotherapy versus cisplatin + 5-fluorouracil + radiotherapy.
    Int J Radiat Oncol Biol Phys, 70(2): 403-12. [Abstract] [Full-text]
52. Involved-field, low-dose chemoradiotherapy for early-stage anal carcinoma.
    Int J Radiat Oncol Biol Phys, 70(2): 419-24. [Abstract] [Full-text]
53. The dose-volume relationship of small bowel irradiation and acute grade 3 diarrhea during chemoradiotherapy for rectal cancer.
    Int J Radiat Oncol Biol Phys, 70(2): 413-8. [Abstract] [Full-text]
54. Clinicopathologic factors identify sporadic mismatch repair-defective colon cancers.
    Am J Clin Pathol, 129(2): 238-44. [Abstract] [Full-text]
55. Noncathartic CT colonography with stool tagging: performance with and without electronic stool subtraction.
    AJR Am J Roentgenol, 190(2): 361-6. [Abstract] [Full-text]
56. Cost consequences of adjuvant capecitabine, Mayo Clinic and de Gramont regimens for stage III colon cancer in the French setting.
    Oncology, 72(3): 248-54. [Abstract] [Full-text]
57. PIK3CA cancer mutations display gender and tissue specificity patterns.
    Hum Mutat, 29(2): 284-8. [Abstract] [Full-text]
58. A nomogram for predicting disease-specific survival after hepatic resection for metastatic colorectal cancer.
    Ann Surg, 247(2): 282-7. [Abstract] [Full-text]
59. Laparoscopic colorectal surgery in elderly patients: a matched case-control study in 178 patients.
    J Am Coll Surg, 206(2): 255-60. [Abstract] [Full-text]
60. Adequacy and importance of lymph node evaluation for colon cancer in the elderly.
    J Am Coll Surg, 206(2): 247-54. [Abstract] [Full-text]
61. Expansion of a mutated clone: from stem cell to tumour.
    J Clin Pathol, 61(2): 164-71. [Abstract] [Full-text]
62. Hyperplastic/serrated polyposis in inflammatory bowel disease: a case series of a previously undescribed entity.
    Am J Surg Pathol, 32(2): 296-303. [Abstract] [Full-text]
63. Metastatic human colonic carcinoma: molecular imaging with pretargeted SPECT and PET in a mouse model.
    Radiology, 246(2): 497-507. [Abstract] [Full-text]
64. Mesorectal fascia invasion after neoadjuvant chemotherapy and radiation therapy for locally advanced rectal cancer: accuracy of MR imaging for prediction.
    Radiology, 246(2): 454-62. [Abstract] [Full-text]
65. Perceived stress and risk of colorectal cancer in men and women: a prospective cohort study.
    J Intern Med, 263(2): 192-202. [Abstract] [Full-text]
66. "You're one of us now": young people describe their experiences of predictive genetic testing for Huntington disease (HD) and familial adenomatous polyposis (FAP).
    Am J Med Genet C Semin Med Genet, 148(1): 47-55. [Abstract] [Full-text]
67. Colorectal carcinoma: in vitro evaluation with high-spatial-resolution 3D constructive interference in steady-state MR imaging.
    Radiology, 246(2): 444-53. [Abstract] [Full-text]
68. Colorectal cancer screening: a comparison of 35 initiatives in 17 countries.
    Int J Cancer, 122(6): 1357-67. [Abstract] [Full-text]
69. CS-706, a novel cyclooxygenase-2 selective inhibitor, prolonged the survival of tumor-bearing mice when treated alone or in combination with anti-tumor chemotherapeutic agents.
    Int J Cancer, 122(6): 1384-90. [Abstract] [Full-text]
70. Aberrant expression of SOX2 upregulates MUC5AC gastric foveolar mucin in mucinous cancers of the colorectum and related lesions.
    Int J Cancer, 122(6): 1253-60. [Abstract] [Full-text]
71. Aurora-A and Cyclin D1 polymorphisms and the age of onset of colorectal cancer in hereditary nonpolyposis colorectal cancer.
    Int J Cancer, 122(6): 1273-7. [Abstract] [Full-text]
72. Germline hypermethylation of the APC promoter is not a frequent cause of familial adenomatous polyposis in APC/MUTYH mutation negative families.
    Int J Cancer, 122(6): 1422-5. [Abstract] [Full-text]
73. Differential sensitivity of human colon cancer cell lines to the nucleoside analogs ARC and DRB.
    Int J Cancer, 122(6): 1426-9. [Abstract] [Full-text]
74. MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma.
    JAMA, 299(4): 425-36. [Abstract] [Full-text]
75. Lung cancer as a second primary malignant tumor: prognostic values after surgical resection.
    Interact Cardiovasc Thorac Surg, 7(1): 50-3. [Abstract] [Full-text]
76. MnSOD protects colorectal cancer cells from TRAIL-induced apoptosis by inhibition of Smac/DIABLO release.
    Oncogene, 27(6): 763-74. [Abstract] [Full-text]
77. Etoposide-resistant HT-29 human colon carcinoma cells during glucose deprivation are sensitive to piericidin A, a GRP78 down-regulator.
    J Cell Physiol, 215(1): 243-50. [Abstract] [Full-text]
78. Regulation of human Cripto-1 gene expression by TGF-beta1 and BMP-4 in embryonal and colon cancer cells.
    J Cell Physiol, 215(1): 192-203. [Abstract] [Full-text]

© 2004-2008 Colorectal Cancer Research Today. All Rights Reserved.